HOME >> MEDICINE >> NEWS
First US kidney cancer vaccine trial underway at Columbia

The first U.S. kidney cancer vaccine trial is now underway at Columbia University Medical Center and NewYork-Presbyterian Hospital/Columbia. While the potential for vaccines to treat solid tumors has been recognized for more than a decade, this trial is pioneering the use of tumor immunotherapy boosting the body's natural immune system as a way to fight cancer.

"Vaccines are an exciting prospect in cancer treatment and this trial is an example of our program's dedication to bringing the latest advances in tumor vaccines and immunotherapy to patients with cancer," said Howard L. Kaufman, M.D., associate professor of surgery and pathology at Columbia University Medical Center and director, Tumor Immunotherapy Program at NewYork-Presbyterian/Columbia. "We expect that combining IL-2 with Trovax will double the treatment response rate for our kidney cancer patients, offering new hope for these patients."

Vaccines, usually associated with the prevention of infectious diseases, e.g., measles, help the body's immune system recognize and kill foreign invading organisms. Recent research has provided evidence that vaccines may also be useful for preventing or treating cancer. Tumor vaccines contain a specific protein of the tumor cell that stimulates an immune response.

In the study, patients with stage IV renal cell carcinoma are given regular doses of an investigational kidney cancer vaccine, called Trovax, in conjunction with Interleukin-2 (IL-2). High-dose IL-2 is currently the only approved treatment for kidney cancer, and Columbia University Medical Center and New York-Presbyterian Hospital/Columbia are the only site in New York to offer IL-2. Kidney cancer is one of the few cancers for which chemotherapies are not effective treatments.

A small protein (cytokine) naturally produced by the cells of the immune system, IL-2 stimulates T-cells, which are activated in an immune response system and create tumor killing cells. The
'"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
27-Jan-2005


Page: 1 2 3

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... , ... METAvivor Research and Support Inc., a non-profit organization dedicated to funding ... Stampede campaign. The campaign will commence with two days of action and education on ... camp, a march, a Die-In (hosted by partner MET-UP), and visits with Congressional offices. ...
(Date:10/8/2019)... ... October 08, 2019 , ... The ... a Digital Health Awards 1st Round (Top Ten) Finalist in its Best ... to select companies that promote faster, better, more cost-effective healthcare by improving outcomes ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... dentistry techniques, has recently attended an advanced Level III training in Cagliari, Italy, ... dentistry. The training took place September 16-19, 2019 at the Sardinia Dental Teaching ...
(Date:10/8/2019)... TORONTO (PRWEB) , ... October 08, 2019 , ... ... at a cost of $28 billion per year, are reproducible. Rigor in bioanalytical ... are increasingly outsourced (by some estimates, more than half of the time) and ...
(Date:10/8/2019)... ... October 08, 2019 , ... U.S. Oral ... that exclusively serves premier oral and maxillofacial surgeons – has formed a new ... practice with two locations near Knoxville, Tennessee. The partnership is USOSM’s first in ...
Breaking Medicine News(10 mins):
(Date:10/10/2019)... (PRWEB) , ... October 10, 2019 , ... This World ... Modern Living with kathy ireland® is pleased to announce their recent interview with ... Essences showcasing how they help consumers of all abilities identify and choose effective hair ...
(Date:10/8/2019)... ... ... Dr. Ryan McNally, ND, MS, PA and Dr. Shashita Inamdar, MD, PhD, DABPN ... presentation titled Advances in Integrative Neuropsychiatry and Functional Mental Health, will evaluate the pros ... health, and reduce the debilitating symptoms of a range of neuropsychiatric disorders. , ...
(Date:10/8/2019)... ... ... For many Americans, dental insurance is limited in what it covers, meaning ... insurance payouts are generally capped at around $1,500—which doesn’t go far. And an estimated ... or older. (Standard Medicare does not cover any dental work.) , When a simple ...
Breaking Medicine Technology:
Cached News: